BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32603789)

  • 1. Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation.
    Singh S; Moore H; Karasik PE; Lam PH; Wopperer S; Arundel C; Tummala L; Anker MS; Faselis C; Deedwania P; Morgan CJ; Zeng Q; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2020 Dec; 133(12):1460-1470. PubMed ID: 32603789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
    Qamer SZ; Malik A; Bayoumi E; Lam PH; Singh S; Packer M; Kanonidis IE; Morgan CJ; Abdelmawgoud A; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2019 Nov; 132(11):1311-1319. PubMed ID: 31150644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
    Malik A; Masson R; Singh S; Wu WC; Packer M; Pitt B; Waagstein F; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2019 Aug; 74(5):617-627. PubMed ID: 31370952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry.
    Patel N; Ju C; Macon C; Thadani U; Schulte PJ; Hernandez AF; Bhatt DL; Butler J; Yancy CW; Fonarow GC
    JACC Heart Fail; 2016 May; 4(5):348-56. PubMed ID: 26874392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
    Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
    J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure.
    Sheriff HM; Thogaripally MR; Panjrath G; Arundel C; Zeng Q; Fonarow GC; Butler J; Fletcher RD; Morgan C; Blackman MR; Deedwania P; Love TE; Aronow WS; Anker SD; Allman RM; Ahmed A
    J Am Med Dir Assoc; 2017 Sep; 18(9):761-765. PubMed ID: 28501416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers.
    Lam PH; Bhyan P; Arundel C; Dooley DJ; Sheriff HM; Mohammed SF; Fonarow GC; Morgan CJ; Aronow WS; Allman RM; Waagstein F; Ahmed A
    Clin Cardiol; 2018 Mar; 41(3):406-412. PubMed ID: 29569405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin and prognosis of heart failure in older patients with preserved ejection fraction: Importance of heart rate. Results from an observational and multicenter study.
    Llàcer P; Núñez J; Bayés-Genís A; Conde Martel A; Cabanes Hernández Y; Díez Manglano J; Álvarez Rocha P; Soler Rangel L; Gómez Del Olmo V; Manzano L; Montero Pérez-Barquero M
    Eur J Intern Med; 2019 Feb; 60():18-23. PubMed ID: 30360944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
    Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
    Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction.
    Malik A; Gill GS; Lodhi FK; Tummala LS; Singh SN; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2020 Jan; 133(1):84-94. PubMed ID: 31336093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
    Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early outcome of initiating amiodarone for atrial fibrillation in advanced heart failure.
    Weinfeld MS; Drazner MH; Stevenson WG; Stevenson LW
    J Heart Lung Transplant; 2000 Jul; 19(7):638-43. PubMed ID: 10930812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure.
    Ahmed A; Bourge RC; Fonarow GC; Patel K; Morgan CJ; Fleg JL; Aban IB; Love TE; Yancy CW; Deedwania P; van Veldhuisen DJ; Filippatos GS; Anker SD; Allman RM
    Am J Med; 2014 Jan; 127(1):61-70. PubMed ID: 24257326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and predictors of digoxin utilization among heart failure patients with reduced ejection fraction in Qatar.
    Rahhal AA; Awaisu A; Tawengi KM; AbuYousef S; Mekideche L
    Int J Clin Pharm; 2017 Oct; 39(5):1070-1083. PubMed ID: 28823072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 17. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry.
    Karthikeyan G; Devasenapathy N; Zühlke L; Engel ME; Rangarajan S; Teo KK; Mayosi BM; Yusuf S;
    Heart; 2019 Mar; 105(5):363-369. PubMed ID: 30209123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin Impact on Heart Failure Patients with Atrial Fibrillation.
    Gerakaris A; Mulita F; Koniari I; Artopoulou E; Mplani V; Tsigkas G; Abo-Elseoud M; Kounis N; Velissaris D
    Med Arch; 2022 Feb; 76(1):23-28. PubMed ID: 35422570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of digoxin for heart failure and atrial fibrillation in elderly patients.
    Cheng JW; Rybak I
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):419-27. PubMed ID: 21335295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.